Cabaletta Bio
Clinical-stage biotechnology company developing engineered T cell therapies for patients with autoimmune diseases, using its Chimeric AutoAntibody Receptor (CAAR) T cell platform.
Website
https://www.cabalettabio.comLocation
Philadelphia, Pennsylvania, USA
Founded
2017
Categories
biotech, cell-therapy, car-t, autoimmune-disease, immunology